29 September 2022

Gout Spondyloarthritis

No heart attack, no worries?

21 September 2022

Fibromyalgia Mental Health Pharmaceuticals TGA

Paracetamol limits flagged as self-harming rises

21 September 2022

Biologics Reactive Arthritis

Reducing risk of HCQ retinopathy comes at a cost

20 September 2022

Reactive Arthritis Research

CAR T-cell therapy shows promise in lupus

15 September 2022

Osteoarthritis Research

Vitamin B12 may help fibromyalgia symptoms

8 September 2022

Vasculitis

Rheumatology’s unspoken cardiac risk

1 September 2022

COVID-19 Reactive Arthritis

The lupus pain in Spain stays mainly when over target again

1 September 2022 SPONSORED

Osteoarthritis

Fibromyalgia in patients with axial spondyloarthritis

1 September 2022

Biologics Spondyloarthritis

Triple therapy: the patients’ perspective

25 August 2022

cardiovascular Conditions Scleroderma

Promising secukinumab results in children

22 August 2022

PBS Reactive Arthritis

Anifrolumab hits PBAC roadblock

18 August 2022 SPONSORED

giant cell arteritis

A synthesis of emerging evidence in inflammatory arthritis

18 August 2022

Complementary Rheumatoid Arthritis

Krill oil may help knee OA symptoms

11 August 2022

Communicable Diseases Gout Spondyloarthritis

How big is the infection risk for JAKi vs TNFi?

11 August 2022

Polymyalgia Rheumatica

Gout flares a red flag for CV risk

4 August 2022

Pharmaceuticals Scleroderma

Risankizumab can be used in patients with Crohn’s